CLINICAL TRIALS PROFILE FOR BRINZOLAMIDE
✉ Email this page to a colleague
All Clinical Trials for BRINZOLAMIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00121147 ↗ | Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan | Completed | Alcon Research | N/A | 2003-09-01 | The purpose of this study is to compare the additive effect on eye pressure of Azopt and Alphagan P to Travatan. |
NCT00121147 ↗ | Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan | Completed | Hermann Eye Center | N/A | 2003-09-01 | The purpose of this study is to compare the additive effect on eye pressure of Azopt and Alphagan P to Travatan. |
NCT00300079 ↗ | Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension | Completed | University of California, San Diego | Phase 4 | 2006-09-01 | This is a multiple-dose study of the IOP-lowering efficacy of Azopt (brinzolamide) 1.0% compared to timolol 0.5% when added to a prostaglandin analogue (PGA) as adjunctive therapy over a 24 hour period in patients with glaucoma or ocular hypertension. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BRINZOLAMIDE
Condition Name
Clinical Trial Locations for BRINZOLAMIDE
Trials by Country
Clinical Trial Progress for BRINZOLAMIDE
Clinical Trial Phase
Clinical Trial Sponsors for BRINZOLAMIDE
Sponsor Name